Blog - Page 1778 of 5720

TuesdayMar 24, 2020 10:20 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Strategic Board Appointments of Three Biotechnology and Healthcare Industry Leaders

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of three new members to its Board of Directors. The new appointments, which include Brent Longnecker, CEO of Longnecker & Associates, Jose A. Moreno Toscano, CEO of LFB USA Inc, and William R. (“Will”) Wilson, Jr., chairman, president and CEO of Wilson Land & Cattle Co., are designed to strengthen Genprex as it executes on its key clinical programs, continues to build its pipeline, and evaluates future license or corporate partnership agreements. “We are honored to have Brent,…

TuesdayMar 24, 2020 10:06 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view…

MondayMar 23, 2020 1:50 pm

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Commences Delivery of $3M to $5M of Rugged and In-Vehicle Push-to-Talk Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it has commenced delivery on its large government tender for up to 15,000 push-to-talk devices, previously announced on December 02, 2019. According to the update, the majority of the order is anticipated to be delivered in Q1 and Q2 and the tender is valued between $3-million to $5-million, depending on the total units and mix between rugged handsets and in-vehicle devices. “Make no mistake, push-to-talk devices are mission critical solutions for public safety workers on the first line of defense; they are supported by dedicated cellular networks to improve communication, while…

MondayMar 23, 2020 1:25 pm

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. These appointments follow on the heels of Genprex’s Fast Track Designation for its lead drug candidate, its newly licensed gene therapy for diabetes, and over $26 million capital raise that will support funding of its clinical programs. “We are delighted to welcome Catherine and Michael to our executive leadership team. They join us at…

MondayMar 23, 2020 12:55 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering…

MondayMar 23, 2020 12:27 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.5 Million in Private Placement

Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced its March 19, 2020, closing on its previously announced private offering of common stock and warrants resulting in gross proceeds of $3,498,612 to the Company. Per the offering, the Company sold and issued 1,650,166 shares of common stock (or common stock equivalents) and issued Series A warrants to acquire 1,650,166 shares of Common Stock at $1.88 per share, exercisable immediately and terminating five and one-half years after the date of…

MondayMar 23, 2020 12:07 pm

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Continues to Accelerate Growth

New operating structure to drive efficiencies, support long-term growth SPRWF implements strategic measures to achieve leading in-store presence and makes representation at an individual store level top priority Positioned to offer investors high growth potential with strong liquidity position, recognized consumer brands and leading infrastructure The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is an innovator in the cannabis sector whose mission is to cultivate the world’s best cannabis and earn recognition as a leader in the global industry. By holding a global and diversified portfolio, the company has emerged as one of the world’s fastest-growing, premium…

MondayMar 23, 2020 11:51 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible. To view the full press release, visit http://ibn.fm/5ILIz About Lexaria Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its…

MondayMar 23, 2020 11:44 am

The Movie Studio Inc. (MVES) Leverages Unique Business Model, Growth by Acquisition Strategy to Secure Leading Market Position

The streaming wars are allowing small competitors like The Movie Studio to capitalize on creatively designed digital business models The company implements a ‘Growth by Acquisition’ strategy, with significant purchases, resolution upgrades and remonetizing initiatives Innovative combination of ‘MovieSodes’ and digital ‘Audition Submission’ upload opportunities among elements propelling the company forward As the advent of streaming wars changes the landscape of delivery of and demand for movie content, The Movie Studio Inc. (OTC: MVES) is emerging as a major brand in the industry. Despite its size as a small competitor, the company's unique business model capitalizes on the increasing worldwide…

Site Search

Company Search